China’s humanoid robot boom faces reality check as 150 companies chase a market where only 23% of buyers are satisfied

China has more than 150 humanoid robot companies. It shipped roughly 90 per cent of the world’s humanoid robots in 2025. Its two largest makers, Unitree and AgiBot, are preparing initial public offerings that would value them at a combined 13 billion dollars. Morgan Stanley doubled its delivery forecast for the Chinese market this year to 28,000 units, a 133 per cent increase over 2025. And yet, when Morgan Stanley surveyed the companies that are supposed to buy these robots, only 23 per cent said they were satisfied with the products available. Battery life tops out at two to three hours per charge. Most deployments remain confined to exhibitions, showrooms, and Spring Festival galas where robots perform kung-fu routines for television cameras. The technology has arrived. The customers have not. China’s humanoid robot industry is the most capitalised, most productive, and most overpopulated robotics sector in the world, and it is heading for a reckoning that its government has already warned is coming.

The warning

In late 2025, China’s National Development and Reform Commission issued a rare public statement about the humanoid robot sector. Spokesperson Li Chao noted that the number of companies had climbed past 150 and was still growing, with more than half being startups or cross-industry entrants. The NDRC warned of redundant products, duplicated investment, and compressed space for genuine research and development. The language was measured. The implication was not. Beijing’s top economic planning agency was telling the market that it saw a bubble forming in the industry it had designated as one of ten priority sectors in the 15th Five-Year Plan, backed by a one-trillion-yuan state fund.

China’s smartphone supply chain has already begun pivoting to humanoid robot production, with companies like Lingyi iTech, a Foxconn supplier that assembles iPhones, targeting 500,000 humanoid units by 2030. The manufacturing infrastructure is real. The component ecosystem is deep. The problem is that the robots being produced are not yet generating the revenue their valuations imply. Unitree, which filed for a 608 million dollar IPO on Shanghai’s STAR Market, saw humanoid robot revenue surpass its quadruped robot business for the first time in 2025, but the company’s total scale remains modest relative to its targeted seven billion dollar valuation. AgiBot, which is aiming for a six billion dollar listing in Hong Kong, is in a similar position: significant technological capability, significant government backing, and a commercial market that has not yet materialised at the scale the IPO price demands.

The gap

The Morgan Stanley survey, led by China industrials analyst Sheng Zhong, found that 62 per cent of Chinese companies said they were likely to adopt humanoid robots within three years. That willingness, however, collided with a set of practical constraints that the industry has not resolved. The 23 per cent satisfaction rate reflected shortcomings in dexterity, functionality, and pricing. Ninety-two per cent of respondents said robots needed to fall below 200,000 renminbi, roughly 28,000 dollars, before mass adoption became viable. Only about 10 per cent of companies surveyed were currently evaluating or running pilot projects. The demand exists in theory. In practice, the robots are too expensive, too limited in capability, and too short on battery life to justify the investment for most industrial applications.

UBTech, one of the sector’s largest players, offered 18 million dollars to recruit a chief AI scientist, a salary that reflects both the intensity of the talent war and the recognition that the engineering challenges remaining are substantial. The Walker S2, UBTech’s latest industrial humanoid, entered mass production in early 2026 with orders exceeding 800 million yuan, and the company is building a factory in Beijing targeting 10,000 units per year by the end of 2026. But production capacity and commercial demand are different things. Morgan Stanley’s Zhong described 2026 as “a critical year as humanoid integrators strive to reach commercialisation and build up their ecosystems,” and warned of an impending shake-out. Production, he noted, is likely to be materially larger than sales, because major players are manufacturing robots internally for training and verification rather than shipping them to paying customers.

The spectacle

In April, a humanoid robot called Lightning, developed by Chinese smartphone maker Honor, won the Beijing E-Town Half-Marathon in 50 minutes and 26 seconds, beating the human world record by nearly seven minutes. More than a hundred robots competed. The event was covered globally. An engineer on the winning team said the achievement enabled technology transfer into structural reliability and cooling that would eventually benefit industrial applications. Robotics experts were less certain. The skills displayed during a half-marathon, sustained bipedal locomotion on a flat surface, do not translate to the manual dexterity, real-world perception, and adaptive problem-solving required for factory work, logistics, or the service applications that the industry’s business plans depend on.

The gap between spectacle and substance defines China’s humanoid robot moment. The Spring Festival Gala performances, the marathon records, and the viral videos of robots doing backflips generate the attention that attracts capital. The capital funds the next round of development. The development produces more impressive demonstrations. But the cycle does not produce revenue at the scale needed to justify the valuations being assigned. China’s industrial model has historically excelled at commercialising technology faster and cheaper than any Western economy, turning solar panels, electric vehicles, and batteries into globally dominant export industries within a decade. The question is whether humanoid robots follow that pattern or whether they represent a category where the gap between demonstration and deployment is structurally wider than the manufacturing advantage can close.

The competition

China’s dominance in humanoid robot shipments has not gone unnoticed. Boston Dynamics began commercial production of its electric Atlas robot in January 2026 and announced plans to deploy tens of thousands of units at Hyundai Motor Group factories, with a manufacturing facility near Savannah, Georgia, targeting 30,000 units per year by 2028. Figure AI, the leading American humanoid startup, holds a 39 billion dollar private valuation after its September 2025 fundraise, despite shipping a fraction of the volume Chinese companies manage. Tesla’s Optimus is performing basic tasks in its own factories, with Elon Musk projecting mass production and a price point of 20,000 to 30,000 dollars, though the robot is, by Musk’s own admission, “not in usage in a material way.” The Pentagon has awarded 24 million dollars in contracts to Foundation Future Industries for humanoid robot soldiers tested in Ukraine, opening a military market that Chinese companies cannot access but that validates the strategic importance governments are placing on the technology.

The pricing dynamics favour China. Unitree’s H2 is positioned below 30,000 dollars. Kepler, another Chinese maker, is targeting the same range. At CES 2026, the sheer number of Chinese humanoid robots on display, and their aggressive pricing, made clear that the supply-side economics are already competitive. The question is whether demand at those price points exists in sufficient volume to sustain an industry with 150 companies competing for it.

The reckoning

Zhong’s prediction of a shake-out is not a minority view. The NDRC’s warning, the Morgan Stanley satisfaction data, the IPO inspection of Unitree just twelve days after its STAR Market application was accepted, and the simple arithmetic of 150 companies chasing a market that delivered roughly 14,000 units in China in 2025 all point in the same direction. The companies that survive will be those that solve the commercialisation problem: identifying repeatable, scalable use cases where the economics of a humanoid robot are superior to the alternatives, whether those alternatives are purpose-built industrial arms, wheeled platforms, or human workers. The companies that do not will have burned through their funding producing impressive machines that no one outside a trade show needed to buy.

China’s humanoid robot industry has the manufacturing base, the component supply chain, the government support, and the engineering talent to lead the world. What it does not yet have is the market. The one-trillion-yuan state fund and the 15th Five-Year Plan designation ensure that capital will continue to flow. The NDRC warning ensures that Beijing is watching how it flows. Somewhere between the billion-dollar IPOs and the 23 per cent satisfaction rate, between the marathon records and the two-hour battery life, is the answer to whether China’s humanoid robot boom produces the next great Chinese export industry or the most expensive collection of trade show demonstrations the technology sector has ever funded. The robots can run a half-marathon faster than any human alive. They cannot yet work an eight-hour shift.